We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.2B
AUM Growth
-$255M
Cap. Flow
-$342M
Cap. Flow %
-28.37%
Top 10 Hldgs %
51.29%
Holding
4,943
New
709
Increased
1,153
Reduced
1,646
Closed
1,310

Sector Composition

Rank Sector Weight
1 Technology 2.73%
2 Financials 2.53%
3 Healthcare 2.3%
4 Consumer Discretionary 2.11%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSQR
3426
DELISTED
BSQUARE Corporation
BSQR
$1K ﹤0.01%
659
+459
+230% +$562
EE
3427
DELISTED
El Paso Electric Company
EE
$1K ﹤0.01%
21
-480
-96% -$32.3K
DO
3428
DELISTED
Diamond Offshore Drilling
DO
$1K ﹤0.01%
125
-5,795
-98% -$33.7K
AA icon
3429
Alcoa
AA
$13.6B
-143
Closed -$3K
A icon
3430
Agilent Technologies
A
$41.7B
-8,406
Closed -$644K
AAL icon
3431
American Airlines Group
AAL
$10.1B
-12,250
Closed -$330K
AAME icon
3432
Atlantic American Corp
AAME
$30.2M
$0 ﹤0.01%
119
-909
-88% -$1.85K
AAON icon
3433
Aaon
AAON
$7.18B
-1,688
Closed -$52K
ABCB icon
3434
Ameris Bancorp
ABCB
$5.84B
-976
Closed -$39K
ABEO icon
3435
Abeona Therapeutics
ABEO
$407M
-18
Closed -$1K
ABG icon
3436
Asbury Automotive
ABG
$3.81B
-1,339
Closed -$137K
ABTS icon
3437
Abits Group
ABTS
$3.85M
-81
Closed -$2K
ABUS icon
3438
Arbutus Biopharma
ABUS
$899M
$0 ﹤0.01%
100
-38,689
-100% -$62.6K
ACLS icon
3439
Axcelis
ACLS
$4.11B
-1,393
Closed -$24K
ACMR icon
3440
ACM Research
ACMR
$5.65B
-11,760
Closed -$54K
ACN icon
3441
Accenture
ACN
$110B
-7,794
Closed -$1.5M
ACP
3442
abrdn Income Credit Strategies Fund
ACP
$634M
-8,066
Closed -$97K
ACR
3443
ACRES Commercial Realty
ACR
$103M
-2,775
Closed -$95K
ACRS icon
3444
Aclaris Therapeutics
ACRS
$861M
$0 ﹤0.01%
218
-5,556
-96% -$9.21K
ACV
3445
Virtus Diversified Income & Convertible Fund
ACV
$286M
-100
Closed -$2K
ADC icon
3446
Agree Realty
ADC
$9.24B
-72
Closed -$5K
ADAP
3447
DELISTED
Adaptimmune Therapeutics
ADAP
$0 ﹤0.01%
162
-21,310
-99% -$22.7K
ADM icon
3448
Archer Daniels Midland
ADM
$38.6B
-13,084
Closed -$537K
ADP icon
3449
Automatic Data Processing
ADP
$108B
$0 ﹤0.01%
2
-7,952
-100% -$1.32M
ADPT icon
3450
Adaptive Biotechnologies
ADPT
$4.12B
-54
Closed -$2K

Similar funds

Tower Research Capital (TRC)'s Q4 2019 Portfolio in Review

As of Q4 2019, Tower Research Capital (TRC) held 4,943 positions worth $1.2B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Tower Research Capital (TRC) withdrew a net $342M in Q4 2019, closing 1,310 positions and reducing 1,646 holdings. Its most notable exit was Wells Fargo, an estimated $7.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 9.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2019 buy was iShares Core S&P 500 ETF: 75,634 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $168M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2019 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $52.3M.
  • Tower Research Capital (TRC) fully exited Wells Fargo in Q4 2019, selling an estimated $7.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 51% of its $1.2B portfolio in Q4 2019.
  • Tower Research Capital (TRC) opened 709 new positions and closed 1,310 in Q4 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.